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Nitric Oxide, Cell Multiplication, and Cell Survival 
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1Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724; 2Koltzov Institute of Developmental Biology, 
Russian Academy of Sciences, Moscow, Russia; 3Department of Genetics, University of Cambridge, United Kingdom 
Arrest of cell division is crucial for cells to enter a 
program of terminal differentiation. In the developing 
organ or a differentiating tissue, growth arrest defines 
roughly the size of the cellular population that is fur- 
ther committed to become a domain of differentiated 
cells. Eventually, the balance between the number of 
cell divisions and the extent of subsequent pro- 
grammed cell death determines the final size of a 
domain, a tissue, or an organ (for review, see Bryant 
and Simpson 1984; Raft 1992, 1996). Mitogenesis, cyto- 
stasis, and survival of neuronal cells can be induced 
and maintained by the same or by different growth or 
trophic factors. The signaling pathways that coordinate 
proliferation, growth arrest, and survival of cells and 
groups of cells in developing organisms are not known, 
but they probably involve as yet undetermined inter- 
and intra-cellular second messenger molecules. 
Nitric oxide (NO) is a diffusible multifunctional 
transcellular messenger that has been implicated in 
numerous physiological functions in mammals, ranging 
from contraction of muscles and dilation of blood ves- 
sels to immune response and potentiation of synaptic 
transmission (for review, see Bredt and Snyder 1994a; 
Nathan and Xie 1994; Garthwaite and Boulton 1995). 
NO is a highly reactive molecule that can spread from 
its original source and act on adjacent cells within a 
restricted volume, displaying properties imilar to both 
paracrine and autocrine effectors. NO is produced 
from arginine by nitric oxide synthase (NOS). Three 
chromosomal NOS genes have been cloned from mam- 
malian cells (for review, see Knowles and Moncada 
1994; Wang and Marsden 1995). These loci give rise to 
numerous NOS isoforms, which differ in their tissue 
distribution, dependence on calcium, and mechanism 
of activation. 
Besides its short-term physiological effects, NO can 
directly affect cell division and cell survival. Depending 
on the biochemical milieu, NO can act in some systems 
as a hazardous agent, inducing mutagenesis, cyto- 
toxicity, and apoptosis. However, in other systems, NO 
can act as a delicate antiproliferative instrument, in- 
ducing temporary cytostasis, which is reversed if the 
concentration of NO decreases. These antiproliferative 
properties of NO may contribute to the cellular 
decision-making processes that control cessation of 
division, entry to a differentiation program, suppres- 
sion or induction of programmed cell death, etc. 
Here, we consider our recent studies to understand 
the role of NO in development. We present evidence 
that NO has a dual role during neuronal cell differen- 
t iat ion-at first it acts as an antiproliferative agent, in- 
ducing growth arrest in dividing cells, and later, when 
the growth arrest is firmly established and the cells 
have undergone differentiation, it helps to suppress 
programmed cell death, thus mediating the survival ef- 
fects of growth factors. Moreover, we have found that 
the antiproliferative f atures of NO enable it to control 
cell number during the development of an intact 
animal. Our results suggest that NO can play a broader 
role as a general regulator of cell proliferation and cell 
survival during organism development and mor- 
phogenesis. 
NO INITIATES A SWITCH FROM 
PROLIFERATION TO CYTOSTASIS DURING 
DIFFERENTIATION OF NEURONAL CELLS 
When naive PC12 cells are exposed to nerve growth 
factor (NGF), they show few signs of neuronal differ- 
entiation within the first 3-4 days. However, after 5-6 
days, the cells stop dividing, enter a cytostatic state, 
and develop a differentiated phenotype: They change 
the pattern of expressed genes, start to express a vari- 
ety of differentiation markers, and, as a most visible 
trait, they send out processes, building a dense network 
of extended and branched neurites (Greene and Tish- 
ler 1976; Greene et al. 1987). Thus, the response of 
PC12 cells to NGF involves a proliferative phase that is 
followed by growth arrest and differentiation. The 
switch from proliferation to cytostasis i critical for the 
cells to establish a differentiated phenotype after ex- 
posure to NGF. If cells cannot establish growth arrest, 
as happens in mutant PCI2-U2 cells, they cannot ac- 
quire a differentiated phenotype and instead continue 
to proliferate (Burstein and Greene 1982). We have 
found that production of NO is crucial for the NGF- 
induced neuronal differentiation of PCI2 cells 
(Peunova nd Enikolopov 1995). Our experiments sug- 
gest that the cytostatic effect of NGF is mediated by 
NO and that induction of NOS is an important step in 
the commitment of neuronal precursors during differ- 
entiation. 
NGF Treatment Induces NOS Activity 
When untreated PC12 cells were tested for NOS by 
the NADPH-diaphorase cytochemical reaction, which 
reflects total NOS activity, no staining was observed. 
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After the cells were treated with NGF, however, they 
gradually started to acquire an intense NADPH- 
dependent blue color after diaphorase staining, indicat- 
ing that NOS accumulates in PC12 cells in response to 
NGF treatment. This increase in diaphorase staining 
was specific for NGF and did not appear after addition 
of fetal calf serum or epidermal growth factor (EGF). 
However, staining was increased after addition of the 
fibroblast growth factor (bFGF), which, like NGF, in- 
duces neuronal differentiation in PCI2 cells. Impor- 
tantly, the NGF-treated cells that were first to undergo 
initial morphological changes characteristic of the dif- 
ferentiated phenotype were also the first to show 
bright staining. This suggests that elevation of NOS ac- 
tivity precedes development of the differentiated 
phenotype. Induction of NOS was confirmed using in 
vitro assays of NOS activity, immunocytochemistry, 
reverse-transcriptase polymerase chain reaction (RT- 
PCR), and RNase protection assays of NOS tran- 
scripts. The results of these assays indicate that during 
the early stages of NGF action, a substantial part of the 
total NOS activity is due to the induction of the Ca §247 
independent NOS2 gene and that the neuronal NOS1 
form is activated much later, following the establish- 
ment of the growth arrest (see also Hirsch et al. 1993). 
NO Can Act as an Antimitogenic Agent in PC12 Cells 
NO can inhibit DNA synthesis in several cell types 
(Garg and Hassid 1989; Lepoivre et al. 1990; Kwon et 
al. 1991; Hogan et al. 1992). It acts as an antimitogenic 
agent in PCl2 cells as well. Several NO donors, sodium 
nitroprusside (SNP), S-nitroso-N-acetylpenicillamine 
(SNAP), and S-nitroso-N-penicillamine (SNOP), sup- 
pressed DNA synthesis in a concentration-dependent 
manner (albeit with different potencies), indicating 
that NO is an active inhibitor of DNA replication in 
PC12 cells. This inhibition, which resulted in a decrease 
in cell division, was not due to cytotoxicity, since the 
cells resumed proliferation once the source of NO was 
removed. NO-mediated inhibition of DNA synthesis 
overcomes the increase of DNA synthesis induced by 
serum, NGF, EGF, bFGF, insulin-like growth factor, 
and various growth factors in combination with NOS 
inhibitors (see below). 
The results of the fluorescence-activated c ll sorting 
(FACS) analysis showed that NO induces specific 
changes in the cell-cycle phase distribution of PCI2 
cells. After treatment with NO donors, cells tended to 
accumulate specifically in G~ phase, and the proportion 
of cells in S phase decreased. Remarkably, within a 
specific range of concentrations of NO donors, the pro- 
portion of PCI2 cells in G 2 and S phases was similar to 
levels reached after prolonged treatment wi h NGF 
(Buchkovich and Ziff 1994; Peunova and Enikolopov 
1995). These results with externally added NO donors 
suggest that NO molecules produced intracellularly 
during the course of NGF action could play a similar 
role in promoting NGF-induced cytostasis. 
Inhibition of NOS Activity Prevents 
Cytostatic Action of NGF 
After several days of NGF treatment, he prolifera- 
tion of PC12 cells ceases and differentiation occurs. If 
NO produced by the NGF-induced NOS in PC12 cells 
can indeed act as a crucial antiproliferative factor, then 
inhibition of the enzyme should uncouple the prolifera- 
tive and cytostatic omponents of NGF action and 
prolong the proliferative phase while suppressing the 
cytostatic effect of NGF. NOS inhibitors N-nitro-L- 
arginine methyl ester (L-NAME), N-monomethyl-L- 
arginine (L-NMMA), and 2-ethyl-2-thiopseudourea 
(ETU) indeed reversed the cytostatic action of NGF 
when applied together with the growth factor, and 
forced the cells to continue to proliferate instead of 
ceasing to divide after several days of NGF treatment. 
In the absence of NGF, similar concentrations of in- 
hibitors did not have a detectable ffect on PC12 cell 
growth; in particular, they did not accelerate cell 
proliferation. Addition of NOS inhibitors also did not 
hinder one of the most important early features of 
NGF action on neuronal cells--rapid induction of a set 
of immediate arly genes (IEGs). Induction of lEGs is 
believed to trigger further steps in a cascade of gene 
activity, ultimately leading to the development of the 
differentiated phenotype. We tested a panel of IEGs 
(c-los, c-jun, fra-l, egr-l, hurT7, and others) by RNase 
protection and found that addition of the NOS in- 
hibitor L-NAME did not affect either their basal level 
of expression or their induction by NGF. This proves 
that the NOS inhibitors do not merely prevent he ini- 
tial steps of NGF action (such as binding to the recep- 
tors, activation of the receptors, induction of the MAP 
kinase signaling pathway) and, in addition, suggests 
that the NOS-dependent s age(s) occurs later in the de- 
velopment of the differentiated phenotype. 
The most visible consequence of NGF action on 
PCI2 cells is neurite outgrowth, and this was also af- 
fected by NOS inhibition. Under normal conditions, al- 
most every cell gradually extends neurites in response 
to NGF, but when PCI2 cells were treated with a com- 
bination of NGF and NOS inhibitor, the number of 
cells with neurites decreased ramatically, in accor- 
dance with the observation that most of the cells con- 
tinued to divide and did not enter the differentiated 
state. In summary, our data show that inhibition of 
NOS reverses the NGF-dependent growth arrest, in- 
dicating that NO mediates the antiproliferative action 
of NGF in neuronal cells. 
NOS Action Is Dependent on Cell Proliferation 
To determine whether in the course of response to 
NGF there is a critical phase during which the cells are 
particularly susceptible to NOS action, PC12 cells were 
treated with NOS inhibitor L-NAME before or after 
the addition of NGF. L-NAME was able to reverse the 
cytostatic action of NGF only when applied before 
NGF addition or within 2-3 days of NGF treatment; 
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after that the inhibitor had no effect. Note that this 
time is shorter than the time needed for full manifesta- 
tion of cytostasis and development of the neuronal 
phenotype. This suggests that the critical time window 
for NO action is within the first days of NGF addition, 
after which NOS may relegate its antiproliferative 
functions to the other, perhaps more general, systems 
of growth arrest. 
To test if the crucial phase of NOS action in NGF- 
treated cells is cell-cycle specific, we uncoupled the 
mitogenic and differentiating phases of NGF action by 
suppressing proliferation of PC12 cells. Cells were 
brought o G O by growth on a medium with low (0.5%) 
serum and then transferred either to low-serum 
medium again or to high (15%)-serum medium and 
treated with combinations of NGF and L-NAME. 
When the cells were transferred to the low-serum me- 
dium (which does not permit cells to cycle), the NOS 
inhibitor could not prevent neurite outgrowth even at 
very high concentrations (10 mM). In contrast, when 
starved cells were transferred to the high-serum me- 
dium, where they could resume proliferation, the same 
concentrations of L-NAME were quite effective at 
suppressing the neurite outgrowth. This implies that if 
growth arrest is established by means other than NO 
production, then NO-mediated induction of cytostasis 
is not evoked and NOS inhibitors do not affect the ac- 
tion of NGF. Taken together, these results argue that 
the critical period of NOS action is dependent on the 
cell cycle progression and that it probably occurs in a 
different phase of the cycle from the decision to enter 
the differentiation program. 
Mutant Cells' Capacity o Differentiate Can Be 
Rescued by NO 
Mutant PCI2-U2 cells retain the early steps of the 
response to NGF but have lost the capacity to execute 
the later steps (Burstein and Greene 1982). They do 
not stop dividing after NGF treatment and, as a con- 
sequence, they do not develop the fully differentiated 
phenotype; in particular, they do not send out pro- 
cesses. To investigate whether this defect is connected 
to NO production, we tested whether the phenotype 
could be overcome by the addition of NO. Although 
neither NGF nor NO alone had any effect on the 
phenotype of U2 cells, in combination these treatments 
restored the differentiated neuronal phenotype. The 
mutant cells stopped dividing and grew extensive 
branched neurites, similar to wild-type PC12 cells. 
Thus, it was possible to rescue the defect in mutant 
cells and to restore the complete differentiation pro- 
gram by complementing NGF action with NO. 
To confirm further the involvement of NOS in the 
differentiation of mutant U2 cells, the induction of 
NOS by NGF in these cells was examined by im- 
munofluorescence and by RT-PCR analysis. Inducible 
NOS (NOS2) was expressed at much lower (almost 
tenfold) levels in U2 cells than in the wild-type PC12 
cells after 4 days of NGF treatment. However, the 
levels of neuronal NOS (NOS1) in U2 cells were in- 
distinguishable from those in PCI2 cells. Together, 
these data demonstrate hat the NGF-treated U2 cells 
are defective in NGF-dependent NOS2 induction and 
that this defect can be rescued by the external applica- 
tion of NO. Importantly, the NOS2 gene is expressed 
in U2 cells, although at low levels, and it can be in- 
duced by means other than NGF. This suggests that the 
defect in U2 cells resides in the signaling regulatory 
pathway rather than in the gene for NOS2 itself. 
In summary, we present evidence for a causative 
role for NO action in NGF-induced growth arrest in 
PCI2 cells. Our experiments argue that NO, produced 
by the NGF-induced NOS, serves as a switch between 
the proliferative and cytostatic phases of NGF action in 
neuronal cells and that NOS activation is necessary for 
the further development of the differentiated pheno- 
type. Our results uggest a role for NOS as a growth ar- 
rest gene in the commitment cascade during NGF- 
mediated ifferentiation of neuronal cells. 
NO MEDIATES SURVIVAL OF FULLY 
DIFFERENTIATED NEURONAL CELLS 
Differentiated neuronal cells become dependent o  
growth factors for survival. NGF is a survival factor for 
sympathetic neurons and for PCI2 cells, and when 
NGF-differentiated PC12 cells are deprived of growth 
factors, they undergo apoptosis. Our studies indicate 
that during the early stages of NGF action, NO ini- 
tiates growth arrest. Here we present evidence that 
during the later stages of NGF action, in fully differen- 
tiated PCI2 cells, NO has an additional role as a 
mediator of the survival functions of NGF. 
Fully Differentiated PC|2 Cells Become 
Dependent on NO 
When growth factors are removed from NGF- 
differentiated PCI2 cells, these cells undergo pro- 
grammed cell death by apoptosis. This process can be 
blocked by reapplying NGF. Since NGF-induced NO 
production remains very high during the late stages of 
NGF action, after growth arrest has been already es- 
tablished, we examined whether part of the NGF ac- 
tion as a survival agent could be supported by NO. We 
have found that NO, like growth factors, can inhibit 
apoptosis of differentiated PCI2 cells after NGF with- 
drawal. When NO-releasing compounds were added to 
fully differentiated cells before or immediately after 
withdrawal of NGF, cell death was markedly reduced, 
demonstrating that NO can partially substitute for 
NGF in preventing apoptosis. This suggests that 
endogenously produced NO, like that produced by NO 
donors, could contribute to cell survival. It may 
mediate some of the survival functions of NGF and 
may be necessary for the suppression of cell death. In- 
deed, inhibition of NOS in fully differentiated cells led 
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to massive death by apoptosis, as documented by 
several criteria (changes in morphology, acridine 
orange and DAPI staining, TUNEL assay, and FACS 
analysis). Importantly, no apoptosis was observed 
when a similar treatment was applied to naive PCI2 
cells or to cells that had been treated with NGF for 2-4 
days and hence had not yet established growth arrest 
and had not differentiated (also see above). Similarly, 
inhibition of NOS did not impair the survival of mutant 
U2 cells, which retain the early steps of the response to 
NGF but have lost the capacity to differentiate. To- 
gether, the results with differentiated, naive, and 
mutant cells indicate that fully differentiated PC12 
cells, in parallel with increased ependence on NGF, 
develop a dependence on NO production for their sur- 
vival, such that inhibition of NOS activity leads to cell 
death, and addition of NO can suppress cell death. 
NO Activates Anti-apoptotic Machinery 
A possible xplanation of the role of NO in prevent- 
ing apoptosis may involve its antiproliferative 
properties. NO may prevent cells from traversing the 
cell cycle, thereby keeping them from reaching a criti- 
cal point where mitogenic signals contradict the estab- 
lished cytostatic ondition of the ceils, prompting them 
to undergo apoptosis (Evan et al. 1992; Ferrari and 
Greene 1994). In addition, inhibition of apoptosis by 
NO may involve direct activation of an anti-apoptotic 
program by NO; for example, by changing the levels of 
expression of proteins that prevent or promote apo- 
ptosis. We tested whether treatment of PC12 cells with 
NO changes the expression of the Bcl-2 family of 
proteins (Bcl-2, Bcl-XL, Bcl-xs, Bax, Bad, Bak, Bag-l) 
involved in regulating programmed cell death (for 
review, see Steller 1995; White 1996; see also Boise et 
al. 1993; Oltvai et al. 1993; Yang et al. 1995) and how 
these changes relate to those induced by NGF. 
Prolonged treatment of PC12 cells with NGF leads to 
an increase in the level of Bcl-XL, a product hat, like 
Bcl-2, can prevent apoptosis in many cell types. At the 
same time, the amount of Bax, a protein that counters 
the ability of Bcl-2 and Bcl-x L to repress apoptosis, 
decreased with a similar time course. In contrast, the 
levels of these proteins are unchanged in the mutant 
U2 cells after NGF treatment, indicating that changes 
in the expression of apoptosis-related genes ar  con- 
nected to withdrawal from the cell cycle and differen- 
tiation, and not just to prolonged NGF treatment. 
Thus, NGF-induced differentiation of PCl2 cells 
changes the expression of genes involved in the cell 
death program in favor of products that prevent apo- 
ptosis. This may lead to a switch of the cell program 
toward prevention of cell death, in line with the known 
role of NGF as a survival factor. 
To determine whether NO can mediate part of the 
effect of NGF on the apoptosis machinery, we sub- 
jected PCI2 cells to sustained treatment with NO 
donors. The changes in expression of a panel of 
apoptosis-related proteins were very similar to the 
changes evoked by NGF treatment. When the same 
donors were added to U2 cells (NGF-treated and un- 
treated), the changes observed were identical to those 
seen in wild-type PC12 cells; most importantly, the 
levels of Bcl-x L were increased, whereas the levels of 
Bax were decreased. Thus, like NGF, NO is able to in- 
duce an anti-apoptotic program directly, and this 
ability of NO may contribute to the survival functions 
of NGF. 
Our results indicate that action of NO is critical in 
both the early and late phases of NGF-driven neuronal 
differentiation, i.e., before and after induction of 
growth arrest. To examine the contribution of different 
NOS isoforms in these two phases of differentiation, 
we followed the expression of various NOS genes by 
Western blot analysis and by RT-PCR. We found that 
differentiation of PC12 cells is accompanied by a 
switch from expression of the inducible form (NOS2) 
soon after addition of NGF (before growth arrest is es- 
tablished), to the neuronal form of NOS (NOSI), 
which reaches the maximal evels after the growth ar- 
rest is established and, perhaps, is more directly associ- 
ated with the survival functions. 
Dual Role of NO in Neuronal Cells 
Our results argue that there is a dual role for NO 
during NGF-driven differentiation of neuronal cells 
(Fig.l). NO acts as an initiator of growth arrest during 
the early stages of NGF action and as a mediator of the 
survival effects of growth factor during the later stages. 
In the proliferative phase of NGF action, the NOS 
gene(s) is induced as a delayed response to the growth 
factor stimulation. This produces enough NO to inhibit 
DNA synthesis and, probably, to activate further 
checkpoints, thereby blocking further progression of 
the cell cycle, completing the proliferative phase of 
NGF action, and switching the cells to the cytostatic 
phase. Thus, NO acts here as a permissive factor for 
the remaining program of differentiation traits (such as 
neurite outgrowth), which can only occur after cell 
division has ceased; in addition, NO probably induces 
some of the later differentiation markers directly by 
promoting gene activity (Peunova and Enikolopov 
1993). 
Later, once growth arrest is established and the cells 
become fully differentiated and dependent on growth 
factors, NO also mediates the cells' survival both by 
enforcing the growth arrest of differentiated cells and 
by activating an anti-apoptotic program. Perhaps the 
switch from expression of the calcium-independent 
form of NOS to the calcium-dependent form underlies 
the dual role for NOS as a trigger of cytostasis in un- 
differentiated cells and as an inhibitor of apoptosis 
in differentiated cells. Given the unconventional 
properties of NO, it is possible that NO diffuses from 
the cell that produces it to promote cessation of growth 
in adjacent cells and that this phenomenon contributes 
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Figure 1. Schematic summary of NGF action and NOS functions. The model relates NGF-induced NOS activity to proliferation, 
differentiation, and survival of PCI2 cells. In the early stages of the NGF action, in dividing undifferentiated cells, NO mediates 
transition to the cytostatic phase and neuronal differentiation. At the later stages, in fully differentiated cells, NO mediates part 
of the survival functions of NGF and prevents cells from programmed cell death both by enforcing the growth arrest and by ac- 
tivating an anti-apoptotic program. 
to the synchronization of development and/or survival 
of a domain of neuronal precursors. 
In the brain, NO production is associated with the 
death of neurons by necrosis and apoptosis after an 
ischemic stroke and, perhaps, neurodegenerative dis- 
eases (Choi 1993; Bredt and Snyder 1994a; Gross and 
Wolin 1995). Paradoxically, NOS-positive neurons in 
the brain are remarkably resistant to damage, and most 
of them are spared after exposure to strong insults and 
diseases that kill other cells (Ferrante t al. 1985, 1987; 
Koh et al. 1986; Koh and Choi 1988a,b; Uemura et al. 
1990; Hyman et al. 1992; Mufson and Brandabur 1994). 
Our results suggest hat preexposure to sustained NO 
production may be responsible for the increased 
resistance of NOS-positive neurons to damage. Al- 
though apoptosis can be initiated by numerous dif- 
ferent stimuli, both the control mechanisms and the 
execution mechanisms of programmed cell death are 
remarkably uniform for different settings and appear 
to involve a relatively limited set of genes. The ability 
of NO to induce an anti-apoptotic program nd pre- 
vent programmed cell death after withdrawal of a 
growth factor may reflect its physiological function in 
the brain during disease. We propose that the unusual 
resistance of NOS-positive neurons in the brain is re- 
lated both to the role of NO in maintaining rowth ar- 
rest and to its ability to fortify the cellular anti- 
apoptotic defense, which may later protect the cells 
from insults. 
NO REGULATES CELL PROLIFERATION 
DURING DROSOPHILA DEVELOPMENT 
Our experiments with cultured cells suggested that 
the antiproliferative activity of NO is crucial for the 
transition from proliferation to differentiation during 
neuronal differentiation. To investigate whether NO 
has a similar role during normal development of 
organisms, we have used Drosophila as a model 
organism. During Drosophila development, he struc- 
ture, size, and shape of most of the organs of the adult 
fly are determined in the imaginal structures of the lar- 
vae (Cohen 1993; Fristrom and Fristrom 1993). Disc 
cells divide rapidly throughout larval development and 
cease proliferating at the end of the third instar period 
(Fig. 2). In leg, wing, and haltere discs, progression 
through the cell cycle stops in G 2 phase 3-4 hours be- 
fore puparium formation. It resumes 15-18 hours later 
and then stops again in a defined spatial pattern after 
12-14 hours (Fain and Stevens 1982; Graves and 
Schubiger 1982; Schubiger and Palka 1987). Although 
most of the dividing cells in the late larvae and in the 
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Figure 2. Schematic summary of cell proliferation in imaginal discs and organ development in Drosophila. Antiproliferative 
properties of NO mediate part of the temporary and, perhaps, terminal growth arrest during development of imaginal discs, and 
thus control the balance between cell proliferation and cell differentiation. 
early pupae are already committed to their adult fate, 
they do not develop a fully differentiated phenotype 
until growth arrest is firmly established. Thus, cell 
proliferation is temporally separated from cell differen- 
tiation, which takes place later during metamorphosis. 
We tested whether NO is involved in the signaling 
pathways that control coordinated temporary growth 
arrest in larvae and pupae and subsequent terminal 
growth arrest in pupae and adults. We have found that 
NO acts as an antiproliferative agent during Drosoph- 
ila development and controls the switch from cell 
proliferation to cell differentiation. Our data suggest 
that NO controls cell number and thus the size of 
anatomical structures in an intact animal. We propose 
that induction of NOS is a crucial step in Drosophila 
development and that NO may be a general regulator 
of cell proliferation and differentiation during organ- 
ism development and morphogenesis. 
NOS Is Expressed in lmaginal Discs during 
Larval Development 
When imaginal discs of the third instar and early 
pupae were examined for the NADPH-diaphorase ac- 
tivity of NOS, staining was observed in all imaginal 
discs, imaginal rings, histoblasts, and the brain of the 
larvae, beginning in the third instar. Staining became 
more intense as development proceeded, indicating ac- 
cumulation of the NOS activity. In late third-instar lar- 
vae and early pupae, a highly specific and reproducible 
pattern of very intense staining was evident. Later in 
development, when the discs began to evert in the 
prepupae, diaphorase staining of the forming struc- 
tures became less intense and a distinct characteristic 
staining pattern of individual segments became evi- 
dent. Diaphorase staining further decreased in a 
specific spatial pattern during early pupal develop- 
ment. Thus, there is a gradual and specific accumula- 
tion of NOS in those developing imaginal structures, 
which undergo radical changes during metamorphosis 
before giving rise to adult organs. This staining reaches 
its highest levels at the time when progression through 
the cell cycle slows down. 
Inhibition of NOS Results in Hypertrophy of
Leg Segments 
The strong antiproliferative properties of NO and 
the specific pattern of diaphorase staining seen i ma- 
ture imaginal discs imply that NO may act as a growth 
arrest agent in these structures and be capable of in- 
hibiting DNA synthesis and supporting temporary 
cytostasis during the switch to metamorphosis. If NO 
indeed acts as an antiproliferative agent during the late 
stages of larval development, hen inhibition of NOS 
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might result in excessive growth of organs and tissues, 
whereas ectopic overexpression f the NOS gene might 
have the opposite ffect. 
To test this hypothesis, we inhibited NOS activity by 
injecting various NOS inhibitors in the developing lar- 
vae at the end of the third instar, several hours before 
metamorphosis. The resulting adults exhibited ramat- 
ic enlargements of many structures: legs, wings, genital 
structures, tergites, and sternites, etc. The changes 
most often affected and were most profound in the legs 
of the adults, where the diameter of certain segments 
increased 3- to 4-fold. The number of bristles and the 
number of rows of bristles were also increased, con- 
firming that hyperproliferation of the cells had oc- 
curred. The leg segments most strongly affected were 
those (first and second tarsal segments, tibia, and 
femur) whose primordia had the highest levels of NOS 
at the larval and prepupal stages. Identical changes 
were observed when structurally unrelated inhibitors 
of NOS were used, indicating that the observed effect 
resulted specifically from blocking NOS activity. To 
test whether changing the NO levels directly affects 
DNA synthesis in the imaginal discs, we labeled the 
nuclei with 5-bromo-deoxyuridine (BrdU) after inhibi- 
tion of NOS activity. There were significantly more 
BrdU-labeled cells in the imaginal discs of flies in 
which NOS activity was blocked than in those of con- 
trol flies. Thus, inhibition of NOS at the late stages of 
larval development results in excessive cell prolifera- 
tion and increased size of the structures of the body of 
the adult fly. 
Ectopic Expression of a Mouse NOS Transgene 
Results in Reduced Size of Leg Segments 
The ability of NO to inhibit DNA synthesis and cell 
proliferation suggests that overexpression of NOS in 
developing larvae may lead to diminished cell 
proliferation in the imaginal discs and to a reduction in 
the size of organs of the adult fly. To increase NO pro- 
duction, we induced xpression of NOS transgene in 
transformed larvae carrying the mouse NOS2 eDNA 
gene under the control of the heat-shock promoter. 
NOS2 is a calcium-independent form of NOS that is 
capable of efficient constitutive NO production. Trans- 
genie larvae were heat shocked within 1 hour after 
pupariation to induce ectopic expression of NOS be- 
fore the final cell divisions take place. This resulted, 
among other changes, in a reduction in the size of the 
limbs of the fly. The distal segments of the legs were af- 
fected most frequently and to the greatest degree. In 
extreme cases, the whole tarsus was shortened 1.5- to 
2-fold and several segments were fused together with 
poorly defined boundaries. The most terminal struc- 
tures of the appendage remained intact in these defec- 
tive legs, suggesting that the observed reduction in size 
was due to incomplete growth of the developing ap- 
pendage, rather than to complete loss of its distal struc- 
tures. The number of bristles in a row on the affected 
segments also decreased, although the number of rows 
did not change. The segments of the adult leg most 
often affected by the overexpression of NOS (third, 
fourth, and fifth tarsal segments) were those that were 
not affected by the NOS inhibitors and whose precur- 
sors exhibited particularly low levels of diaphorase 
staining in the early prepupal stages. In contrast o ex- 
periments with inhibition of NOS, when imaginal discs 
were labeled with BrdU after induction of ectopic NOS 
expression, there were markedly fewer labeled cells in 
imaginal discs from induced NOS-transformed flies 
than in uninduced controls. Thus, ectopic expression of 
NOS at the late stages of larval development results in 
a decrease in cell proliferation and a reduction in the 
size of the structures of the body of the adult fly. 
Inhibition of Apoptosis Unmasks 
Excessive Proliferation 
For some Drosophila structures, for instance, the 
eye, we consistently detected an increase in the num- 
ber of cells in S-phase in the imaginal disc after inhibi- 
tion of NOS, but the resulting adult organ usually ap- 
peared normal. We tested the possibility that the ap- 
parently normal eye phenotype occurred as a result of 
programmed cell death, which counteracts excessive 
cell proliferation induced by NOS inhibition and 
restores the normal number of cells in the eye during 
metamorphosis. To suppress programmed cell death, 
we used GMR-P35 flies in which apoptosis in the de- 
veloping eye is largely prevented by expression of 
recombinant baculovirus p35 protein (Hay et al. 1994). 
When NOS was inhibited in GMR-P35 larvae, the 
eyes of the adult flies showed numerous changes, 
reflecting the surplus proliferation of various cell types 
in the developing eye. The most dramatic of these 
changes was in the number of ommatidia in the adult 
eye, which increased from the nearly invariant comple- 
ment of 750 in wild-type flies and untreated GMR-P35 
flies to nearly 820 after NOS inhibition in GMR-P35 
flies. In addition, different types of accessory cells in 
the ommatidia proliferated after NOS inhibition to 
levels higher than those achieved by blocking apoptosis 
by p35 (Hay et al. 1994). For instance, the number of 
secondary and tertiary pigment cells was increased 
from 12 per sample area in normal eyes to more than 
35 in GMR-P35 flies after inhibition of NOS. This 
number exceeds the maximal number of pigment cells 
saved from programmed cell death in untreated GMR- 
P35 flies (-25 per sample area) and suggests that extra 
pigment cells arise as a result of excessive cell 
proliferation caused by inhibition of NOS combined 
with suppression of cell death caused by p35. Further- 
more, the number of bristles was increased in some 
areas of the eye in GMR-P35 flies after NOS inhibi- 
tion, up to four to five per ommatidium, instead of the 
three seen in normal flies and untreated GMR-P35 
flies. Similarly, the number of cone cells was increased 
from four in normal and in untreated GMR-P35 om- 
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matidia to five and six in many ommatidia of GMR- 
P35 flies after NOS inhibition. Thus, prevention of 
apoptosis in the developing Drosophila eyes revealed 
excessive proliferation of various cell types after NOS 
inhibition, which was otherwise masked by pro- 
grammed cell death in the larvae and pupae. 
Together, our experiments with Drosophila have 
demonstrated that inhibition of NOS in larvae leads to 
enlargement of organs in adults and, conversely, that 
ectopic expression of NOS in larvae leads to a reduc- 
tion in the size of organs in adults. In addition, the dis- 
tribution of affected segments in the adult leg cor- 
responds to the distribution of NOS in the larvae, and 
the changes in segment size can be directly correlated 
to changes in DNA synthesis in imaginal discs after 
manipulations of NOS activity. The increased cell 
proliferation that occurs in response to NOS inhibition 
is masked in some structures by apoptosis, and it can 
be revealed by suppressing programmed cell death. 
Taken together, these results indicate that NO acts as 
an antiproliferative agent to control cell proliferation 
during Drosophila development (Fig. 2). 
NO AND DEVELOPMENT 
This study provides upport for the hypothesis that 
NO acts as an antiproliferative agent during cell differ- 
entiation and organism development and controls the 
cell number in an intact developing organism. It sug- 
gests a novel role for NO as a regulator of the balance 
between cell proliferation and cell differentiation dur- 
ing development. How general is the phenomenon of 
NO-mediated growth arrest in organism development? 
NOS expression can be induced to high levels in a large 
number of tissues and cell types by appropriate 
stimulation (Bredt and Snyder 1994a; Forstermann et 
al. 1995). In most cases, the pattern of NOS distribu- 
tion in a developing organism differs strongly from the 
distribution in the adult organism. Furthermore, 
transient elevation of NOS expression in a given tissue 
often coincides with the cessation of division of com- 
mitted precursor cells. For instance, in the brain, a 
strong elevation of NOS activity in the developing 
cerebral cortical plate and hippocampus at days 15-19 
of embryonic development correlates with the time 
course of cessation of precursor cell proliferation, tight 
growth arrest, and cell differentiation; notably, NOS 
activity goes down after the proliferation of committed 
neuronal precursors is completed (Bredt and Snyder 
1994b; Blottner et al. 1995). NOS levels are also 
transiently increased in developing lungs, bones, blood 
vessels, nervous ystem, and other tissues and organs 
(Blottner et al. 1995; Collin-Osdoby et al. 1995; Cramer 
et al. 1995; Shaul 1995; Wetts et al. 1995). Elsewhere, 
NOS activity is greatly elevated in regenerating tissues 
when cessation of cell division is crucial for prevention 
of unregulated growth (Roscams et al. 1994; Blottner 
et al. 1995; Decker and Obolenskaya 1995; Hortelano 
et al. 1995). In all these cases, a transient elevation of 
NOS activity might trigger a transition from prolifera- 
tion to growth arrest and differentiation, thus con- 
tributing to the proper morphogenesis of the tissue and 
the organ. 
We propose that production of NO is required dur- 
ing embryonic development and during tissue 
regeneration i the adult organism for the proper con- 
trol of cell proliferation. The antiproliferative prop- 
erties of NO may be particularly important in situa- 
tions in which terminal differentiation of committed 
cells is temporally separated from cell proliferation and 
is strictly dependent on cessation of cell division. Given 
the multiplicity of the NOS isoforms, their overlapping 
tissue distribution, and the possibility that NO can be 
transferred within the organism by hemoglobin (Jia et 
al. 1996), it is conceivable that any group of cells in the 
embryo and fetus can be exposed to NO action. 
NO is easily diffusible, and it may therefore exert its 
antiproliferative properties not only in the cell that 
produces it, but in the adjacent cells as well. Thus, it is 
possible that NO can contribute to the coordinated e- 
velopment of a group of neighboring cells committed 
to form a particular structure and thus may participate 
in tissue and organ morphogenesis. An efficient source 
of readily diffusible transcellular messengers, such as 
NO, may induce synchronized changes in the adjacent 
cells within a limited volume of a tissue. Moreover, 
several adjacent cells producing easily diffusible 
antiproliferative molecules may share the total pool of 
these molecules, produced by the neighbors as well as 
by themselves. If a particular threshold level of a signal 
is needed to initiate a signaling chain that eventually 
leads to growth arrest, then the cells in this group could 
stop dividing when a certain number of cells and, 
therefore, a certain local concentration of messenger 
molecules i  reached. This way, by organizing roups of 
cells in functional clusters, NO may instruct he devel- 
oping structures to terminate their growth when they 
attain the appropriate size and shape, at the same time 
coordinating their growth with the growth of the ad- 
jacent issues. 
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